← back to search

Tadaki Suzuki

National Institute of Infectious Diseases ·
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, and Respiratory viral infections research.
h-index
59
citations
16,844
works
401
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Three Cases of Vertical Transmission of Clade Ib Mpox Virus
New England Journal of Medicine 2025cited by 9position: middledoi
Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan
Open Forum Infectious Diseases 2023cited by 15position: middledoi
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan
Vaccine 2023cited by 12position: middledoi
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)
Vaccine 2023cited by 11position: middledoi
Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies
Eurosurveillance 2023cited by 5position: middledoi
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Nature 2022cited by 694position: middledoi
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
New England Journal of Medicine 2022cited by 323position: middledoi
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Proceedings of the National Academy of Sciences 2020cited by 1,165position: middledoi
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Science 2020cited by 999position: middledoi
MCPIP1 reduces HBV-RNA by targeting its epsilon structure
Scientific Reports 2020cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2020–2020)— · 1 papers (2020–2020)— · 1 papers (2020–2020)— · 1 papers (2020–2020)Seiya Yamayoshi · University of Wisconsin–Madison1 papers (2022–2022)— · 1 papers (2020–2020)Yuko Sato · Iowa State University1 papers (2020–2020)Harm van Bakel · University of Wisconsin–Madison1 papers (2022–2022)Masaki Imai · Gunma University1 papers (2022–2022)Andrew Pekosz · Johns Hopkins University1 papers (2022–2022)Xin Zheng · Sun Yat-sen University Cancer Center1 papers (2020–2020)— · 1 papers (2020–2020)Koichi Watashi · Shanghai Medical College of Fudan University1 papers (2020–2020)Peter Halfmann · University of Wisconsin–Madison1 papers (2022–2022)Emilia Mia Sordillo · Icahn School of Medicine at Mount Sinai1 papers (2022–2022)Yoshihiro Kawaoka · University of Wisconsin–Madison1 papers (2022–2022)— · 1 papers (2020–2020)Ken Maeda · The University of Texas Medical Branch at Galveston1 papers (2022–2022)Hideki Hasegawa · Institut de Recherche Vaccinale1 papers (2022–2022)Yuko Sakai‐Tagawa · Tokyo University of Science1 papers (2022–2022)